Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:12 PM
Ignite Modification Date:
2025-12-26 @ 5:12 PM
NCT ID:
NCT02265406
Eligibility Criteria:
Inclusion Criteria:
* Brain injured patients with a Glasgow scale score ≤ 12 who require ventilation more than 48 hours
Exclusion Criteria:
* Patient with a high risk of death within the 48 first hours after admission,
* Patient intubated for more than12 hours
* Intubation after the 48th hours after admission
* Coverage to cardiopulmonary arrest
* Coma due to a tumor, an infectious disease or a cardiac arrest
* Previous hospitalisation within the last month before admission for coma
* béta-lactamines allergy
* Patient who receive already antibiotics at the admission for a previous infection
* Prophylactic antibiotic due to be done within 24 hours following the randomisation
* Patient Intubated through a tracheal tube with subglottic secretion aspiration
* Patient with a tracheotomy
* Patient or family refuse to be involved in the study
* Use of Ceftriaxone within 2 days before enrolment
* Participation in another research protocol focusing on an anti-infective treatment or on a measure decreasing the risk of infection
* Patients not affiliated to a social security scheme, Pregnant woman or breast-feeding mother, Patients deprived of their liberty by judicial or administrative decision
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02265406
Study Brief:
Protocol Section:
NCT02265406